A recent study, published in the prestigious scientific journal Nature, has attracted significant attention and created considerable confusion in recent weeks. The title of the study simply states “Asparagine bioavailability governs metastasis in a model of breast cancer.” As a scientist, when I read the study, the caveats implicit in this title are clear. The key words of caution regarding this study are “in a model of breast cancer.” This clearly indicates to the scientific community at least, that the authors are openly acknowledging that this study cannot be interpreted as directly translatable to human patients. However, less cautious interpretations of this study have led to extraordinary claims being made in the lay press and on social media. Read more… “In the News: Asparagus and Breast Cancer”
I recently attended the annual Obesity Week conference, a joint meeting hosted by The Obesity Society and the American Society for Metabolic and Bariatric Surgery (ASMBS), in National Harbor, Maryland. Given the scale, complexity and impact of overweight and obesity on health and wellness, it was encouraging to see that these problems are being addressed from every possible angle.
Three sessions at the conference were focused on obesity and cancer; in addition, AICR sponsored a special cancer-focused issue of the Obesity Journal, timed to coincide with Obesity Week. The research presented covered the full spectrum from lab studies to human interventions and policy advice on the links between obesity and cancer.
The defining moment for me was how cancer researcher Dr. Stephen Hursting captured the mood of the meeting perfectly saying: “We need to stop asking, “Is obesity a risk factor for cancer?” Yes. It is. Now we need to focus on how to reduce the impact of obesity on cancer risk and outcomes”. Read more… “Obesity and Cancer Research, Finding Solutions that Fit”